Cardiol Res
Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website http://www.cardiologyres.org

Original Article

Volume 8, Number 6, December 2017, pages 280-285


Evaluation of the Tp-Te Interval, QTc and P-Wave Dispersion in Patients With Coronary Artery Ectasia

Ronan Conlona, Richard Tannera, Santhosh Davida, Gabor Szeplakib, Joseph Galvinb, John Keaneyb, Edward Keelanb, Usama Bolesa, b, c

aLetterkenny University Hospital, Letterkenny, Co. Donegal, Ireland
bHeart and Vascular Center, Mater Private Hospital, Dublin 2, Ireland
cCorresponding Author: Usama Boles, Heart and Vascular Center, Mater Private Hospital, Dublin 2, Ireland

Manuscript submitted November 10, 2017, accepted November 30, 2017
Short title: Coronary Artery Ectasia
doi: https://doi.org/10.14740/cr631w

Abstract▴Top 

Background: Coronary artery ectasia (CAE) is defined as a diffuse dilatation of the diameter of the ectatic segment of the coronary artery, 1.5 times greater than that of the adjacent segment. The Tp-Te interval, P-wave and QTc dispersions are relatively new electrocardiographic markers associated with an increased risk of developing arrhythmias. Despite CAE increasing in prevalence in recent years, there is a sparsity of data available about its arrhythmogenic effect. The aim of the study was to evaluate QTc, P-wave dispersion and Tp-Te and Tp-Te/QT ratio in patients with CAE.

Methods: A retrospective comparative study was designed for consecutive age- and sex-matched patients. Twenty patients with isolated CAE (group 1) and 20 control subjects (group 2), with normal coronary arteries, were included. All patients presented with chest pain and coronary angiogram was indicated. Outcome measures included Tp-Te interval, Tp-Te/QT ratio, QTc dispersion and P-wave dispersion. Measurement of electrocardiogram (ECG) parameters was conducted using standardized digital online software. Descriptive and inferential statistics were performed.

Results: Mean Tp-Te (95.5 ± 9.01 ms) and Tp-Te/QT ratio (0.22 ± 0.02) were significantly prolonged in CAE group (Tp-Te: 84 ± 5.62 ms, P = 0.00009; Tp-Te/QT ratio: 0.20 ± 0.01, P = 0.00004). In addition, QTc (31.2 ± 3.71 ms) and P-wave dispersion (31.9 ± 5.46 ms) were significantly increased in comparison to the control group (QTc: 27.6 ± 2.82 ms, P = 0.00532 and 20 ± 3.77 ms, P = 0.00003 respectively). However, there was no difference in ventricular activation time (VAT) between groups.

Conclusions: CAE ECGs were found to be associated with increased Tp-Te, Tp-Te/QT ratio, QTc intervals and P-wave dispersions. This may suggest that CAE existence has a pro-arrhythmogenic nature.

Keywords: Coronary artery ectasia; Tp-Te interval; QTc dispersions; Arrhythmia; P-wave dispersions; Tp-Te/QT ratio

Introduction▴Top 

Coronary artery ectasia (CAE) has been defined dilatation of a coronary vessel segment up to 1.5 times the diameter of the adjacent vessel and including more than a third of the total length of the vessel [1]. The pathophysiology and clinical significance of CAE is poorly understood. Suggested etiologies include atherosclerosis, congenital abnormalities, inflammatory and/ or connective tissue diseases [2, 3].

The interval from the peak of the T wave to the end of the T wave (Tp-Te interval), on a standard 12-lead electrocardiogram (ECG), is a measure of transmural dispersion of repolarization in the left ventricle [4-6], with prolongation representation a period of possible susceptibility to ventricular arrhythmias [7, 8]. A prolonged Tp-Te interval has been associated with an increased risk of mortality in hypertrophic cardiomyopathy, in patients undergoing primary percutaneous coronary intervention for myocardial infarction, and in congenital and acquired long-QT syndromes [9-11]. Limited data are available with regard to the effect that CAE has on the Tp-Te interval, which is important given its potential arrhythmogenic effect (Fig. 1).

Figure 1.
Click for large image
Figure 1. The Tp-Te interval, QTc and P-wave dispersion.

Other ECG parameters such as QTc dispersion, which has been defined as the difference between the longest and shortest QT interval and P-wave dispersion (PWD), which is calculated by subtracting the minimum P-wave duration from the maximum in a 12-lead ECG (Fig. 1), are important measurements and have been implicated in the development of both ventricular and atrial arrhythmias respectively [12-14]. In the present study, we examine the Tp-Te interval, QTc and PWD in patients with CAE, to assess whether an apparently benign disease has a pro-arrhythmogenic effect.

Materials and Methods▴Top 

A retrospective chart review of 1,650 consecutive angiograms, between January 2014 and January 2017, was conducted to identify patients with CAE [15]. Patients with known previous myocardial infarction (MI), atrial fibrillation, bundle branch blocks, ventricular preexcitation and atrioventricular conduction abnormalities were excluded from the study. Also, patients on any antiarrhythmic drugs that may have an effect on ECGs parameters were excluded. A total of 20 patients with isolated CAE (group 1) were identified and compared to 20 control subjects (group 2), with normal coronary arteries. All patients presented with chest pain and following non-invasive tests for risk stratification, for ischemic heart disease a coronary angiogram was indicated. Both groups were matched for age and sex as well as cardiovascular risk factors including: hypertension, family history of ischemic heart disease, diabetes mellitus, smoking history and dyslipidemia.

All ECGs were measured at rest, using a 12-lead high resolution ECG (GE, MAC 5000, New York) with 1 mV/cm amplitude and 25 mm/s rate. Outcome measures included Tp-Te interval, Tp-Te/QT ratio, QTc dispersion, PWD and VAT.

Tp-Te interval and Tp-Te/QT ratio

The Tp-Te interval was measured from the peak of the T wave to the end of the T wave. The end of the T wave was defined as the intersection of the tangent to the down slope of the T wave and the isoelectric line [16]. The QT interval was measured from the earliest onset of the QRS complex to the end of the T wave (Fig. 1). When a U wave interrupted the T wave prior to returning to baseline, the interval was measured to the nadir of the curve between the T and U waves.

The Tp-Te/QT ratio was calculated as the ratio of Tp-Te in lead V5 to the corresponding QT interval in the same lead [9]. The Tp-Te and QT interval were measured in lead V5 [9, 17].

QTc dispersion

QTc dispersion was defined as the difference between the longest and shortest QT intervals and rate corrected using Bazett’s formula, as the heart rate was found to be under 100 bpm in all ECGs [12].

PWD

PWD was calculated by subtracting the minimum P-wave duration from the maximum in any of the 12 ECG leads (Fig. 1). The beginning of the P wave was defined as the point where the initial deflection of the P wave crossed the isoelectric line and the end was defined as the point where the final deflection of the P wave crossed the isoelectric line.

Ventricular activation time (VAT)

VAT was defined as the average measurement from the onset of the Q wave to the peak of the R wave. The measurements from V6 were comparable with the mean value calculated from 12 leads as previously validated [18].

ECG measurements

Measurement of ECG parameters was conducted manually using digital online software (Cardio Calipers, Iconico, New York, NY), by a blinded observer. A second blinded observer repeated all ECG measurements using the same technique and the two subsets of data were compared to ensure there was no inter-observer variability (P > 0.05).

Statistical analysis

Descriptive and inferential statistics were performed using Stata 13 (StataCorp CP, College Station, TX). An unpaired t-test was used to compare groups. Statistical significance was set at P < 0.05.

Results▴Top 

Demographics

Baseline demographics of age, gender and cardiovascular risk factors including: hypertension, family history of ischemic heart disease, diabetes mellitus, smoking history and dyslipidemia were all listed in Table 1. There was no significant difference between both groups. Hypertension was defined in accordance with the JNC-7 guidelines as a systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg and/or use of antihypertensive medications. Family history of CAD was noted if a male first-degree relative developed CAD before the age of 55 or a female first-degree related before 65. Diabetes was defined as overnight fasting blood glucose ≥ 7 mmol/L (126 mg/dL), postprandial blood glucose ≥ 11 mmol/L (200 mg/dL) or use of insulin or oral hypoglycemic agents. Patients were classified as smokers if they had smoked during the last month. Dyslipidemia was defined as a total cholesterol ≥ 6.2 mmol/L (240 mg/dL), low-density lipoprotein cholesterol ≥ 4.14 mmol/L (160 mg/dL) or use of lipid-lowering medications [19].

Table 1.
Click to view
Table 1. Demographics and Cardiovascular Risk Factors: Group 1 Versus Group 2
 

CAE/ECG comparison with control

In Table 2, all the predefined intervals were compared and showed results as follows.

Table 2.
Click to view
Table 2. Comparison of ECG Intervals Between CAE Group and Control Group
 

Tp-Te interval and Tp-Te/QT ratio

Mean Tp-Te (95.5 ± 9.01 ms) and Tp-Te/QT ratio (0.22 ± 0.02) were significantly prolonged in group 1, compared to group 2 (Tp-Te: 84 ± 5.62 ms, P = 0.00009; Tp-Te/QT ratio: 0.20 ± 0.01, P = 0.00004).

QTc dispersion and PWD

CAE/ECG measurements of QTc (31.2 ± 3.71 ms) and PWD (31.9 ± 5.46 ms) were significantly higher in comparison to group 2 (QTc: 27.6 ± 2.82 ms, P = 0.00532; PWD: 20 ± 3.77 ms, P = 0.00003).

VAT

There was no significant difference in VAT duration between groups (group 1: 42 ± 2.63 ms, group 2: 43.72 ± 3.23 ms, P = 0.22).

Discussion▴Top 

The present study represents an assessment of pertinent ECG markers associated with arrhythmias in patients with CAE. CAE was found to be associated with a prolonged Tp-Te interval, QTc and PWD. These findings suggest that CAE, an apparently benign disease, may in fact have a pro-arrhythmogenic effect.

CAE is a relatively rare coronary anomaly, found in approximately 5% of patients undergoing coronary angiography [2]. Ectatic coronary arteries have been found to be associated with myocardial ischemia, thrombosis, spasm, dissection and rupture [20-22]. In addition, they have been associated with electrical instability, ventricular fibrillation and sudden death [22, 23].

Tp-Te interval

Tp-Te interval is a measure of transmural dispersion of repolarization in the left ventricle, with prolongation representing a period of possible susceptibility to ventricular arrhythmias [7, 8]. A proposed mechanism for this phenomenon was suggested by Antzelevitch and coworkers [24, 25]. Three electrophysiological distinct cell types exist in the ventricular myocardium, which include the endocardial, epicardial and subendocardial M cells (Masonic mid-myocardial Moe cells). The action potential of the M cells is the most susceptible to prolongation [6], likely because of a combination of larger late-sodium and sodium/calcium exchange currents as well as a weaker slowly activation delayed rectifier current [26]. The Tp-Te interval corresponds with transmural dispersion of repolarization in the ventricular myocardium, a period where the epicardium has fully repolarized but the M cells are still in the process of repolarization, making them more vulnerable to early after-depolarizations [16, 17]. These early after-depolarizations can lead to reentry, which could result in a polymorphic ventricular tachycardia or ventricular fibrillation, hence why a prolonged Tp-Te likely corresponds to an extended period of vulnerability that could increase the risk of ventricular arrhythmogenesis [7, 27-29].

In the present study, the Tp-Te interval was found to be longer in the CAE group. Our results were consistent with another study conducted by Karaagac et al [30], where the Tp-Te interval was found to be significantly increased in patients with isolated CAE. In their study, the mean Tp-Te interval was found to be 97.71 ± 8.7 ms in patients with CAE, compared to 85.23 ± 7.1 ms in the group with normal coronary arteries [30].

A disproportionate increase in transmural dispersion of repolarization relative to the total duration of repolarization (Tp-Te/QT ratio) has previously been shown to have a pro-arrhythmic effect [31]. It has been proposed as a marker of arrhythmogenesis for long QT-syndrome as well as hypertrophic cardiomyopathy [9, 32]. In the present study, mean Tp-Te/QT ratio was significantly greater among patients with CAE compared to controls.

QTc dispersion

QTc dispersion is emerging as an important clinical tool as it is known to be an important factor in the development of ventricular arrhythmias in patients with chronic heart failure, mitral valve prolapse, MI and familial long QT syndrome [13, 33-35]. In the present study, isolated CAE was associated with a significantly increased QTc in comparison to the control group. Our findings are consistent with another study, which also found QTc dispersion to be increased in patients with CAE [36].

PWD

PWD is thought to reflect prolongation of both intra-artial and interatrial conduction time and the inhomogeneous propagation of sinus impulses, which are known electrophysiological features in patients with atrial arrhythmias [14]. A prolonged PWD time has been reported to increase the risk of developing atrial fibrillation in patients with no underlying heart disease [37, 38]. Our results were consistent with another study, which demonstrated a statistically significant increase in PWD time in patients with CAE [36].

Conclusions

CAE was found to be associated with prolongation of the Tp-Te interval, QTc and PWD. Our data suggest that these patients may be more susceptible to developing both ventricular and atrial arrhythmias. Routine measurement of the aforementioned ECG parameters in clinical practice may be useful in risk stratifying these patients. Further prospective studies are warranted to quantify arrhythmia burden in CAE patients.


References▴Top 
  1. Yetkin E, Ozturk S. Coronary artery aneurysm and coronary artery ectasia: what makes the difference? Angiology. 2017;68(9):833.
    doi pubmed
  2. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, Foussas SG, et al. The natural history of aneurysmal coronary artery disease. Heart. 1997;78(2):136-141.
    doi pubmed
  3. Williams MJ, Stewart RA. Coronary artery ectasia: local pathology or diffuse disease? Cathet Cardiovasc Diagn. 1994;33(2):116-119.
    doi
  4. Taggart P, Sutton PM, Opthof T, Coronel R, Trimlett R, Pugsley W, Kallis P. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res. 2001;50(3):454-462.
    doi
  5. Opthof T, Coronel R, Janse MJ. Is there a significant transmural gradient in repolarization time in the intact heart?: Repolarization Gradients in the Intact Heart. Circ Arrhythm Electrophysiol. 2009;2(1):89-96.
    doi pubmed
  6. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA, et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991;69(6):1427-1449.
    doi pubmed
  7. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98(18):1928-1936.
    doi
  8. Antzelevitch C, Shimizu W, Yan GX, Sicouri S. Cellular basis for QT dispersion. J Electrocardiol. 1998;30(Suppl):168-175.
    doi
  9. Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K, Itoh H, et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol. 2002;25(7):335-339.
    doi pubmed
  10. Haarmark C, Hansen PR, Vedel-Larsen E, Pedersen SH, Graff C, Andersen MP, Toft E, et al. The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol. 2009;42(6):555-560.
    doi pubmed
  11. Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M, Belhassen B, et al. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol. 2007;49(3):320-328.
    doi pubmed
  12. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett’s formula in myocardial infarction. Am Heart J. 1985;109(3 Pt 1):568-574.
    doi
  13. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343(8893):327-329.
    doi
  14. Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis. 2016;5:2048004016639443.
    doi pubmed
  15. Boles U, Rakhit R, Shiu MF, Patel K, Henein M. Coronary artery ectasia as a culprit for acute myocardial infarction: review of pathophysiology and management. Anadolu Kardiyol Derg. 2013;13(7):695-701.
    doi
  16. Perkiomaki JS, Koistinen MJ, Yli-Mayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol. 1995;26(1):174-179.
    doi
  17. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-357.
  18. Boles U, Almuntaser I, Brown A, Murphy RR, Mahmud A, Feely J. Ventricular activation time as a marker for diastolic dysfunction in early hypertension. Am J Hypertens. 2010;23(7):781-785.
    doi pubmed
  19. Nicoll R, Wiklund U, Zhao Y, Diederichsen A, Mickley H, Ovrehus K, Zamorano P, et al. The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: Euro-CCAD study. Int J Cardiol. 2016;207:13-19.
    doi pubmed
  20. Suzuki H, Takeyama Y, Hamazaki Y, Namiki A, Koba S, Matsubara H, Hiroshige J, et al. Coronary spasm in patients with coronary ectasia. Cathet Cardiovasc Diagn. 1994;32(1):1-7.
    doi pubmed
  21. Perlman PE, Ridgeway NA. Thrombosis and anticoagulation therapy in coronary ectasia. Clin Cardiol. 1989;12(9):541-542.
    doi
  22. Satoda M, Tatsukawa H, Katoh S. Images in cardiovascular medicine. Sudden death due to rupture of coronary aneurysm in a 26-year-old man. Circulation. 1998;97(7):705-706.
    doi pubmed
  23. Karakaya O, Saglam M, Barutcu I, Esen AM, Turkmen M, Kargin R, Esen O, et al. Effects of isolated coronary artery ectasia on electrocardiographic parameters reflecting ventricular heterogeneity. J Electrocardiol. 2007;40(2):203-206.
    doi pubmed
  24. Antzelevitch CSW, Yan GX. Electrical heterogeneity and the development of arrhythmias. In: Olsson SB, Yuan S, Amlie JP, editors. Dispersion of ventricular repolarization:state of the art. Armonk (NY): Futura Publishing Company; 2000. p. 3.
  25. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res. 1991;68(6):1729-1741.
    doi pubmed
  26. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol. 2007;293(4):H2024-2038.
    doi pubmed
  27. Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, et al. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol. 1999;10(8):1124-1152.
    doi pubmed
  28. Emori T, Antzelevitch C. Cellular basis for complex T waves and arrhythmic activity following combined I(Kr) and I(Ks) block. J Cardiovasc Electrophysiol. 2001;12(12):1369-1378.
    doi pubmed
  29. Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M, Mikami Y, et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol. 2004;37(3):191-200.
    doi pubmed
  30. Karaagac K, Yontar OC, Tenekecioglu E, Vatansever F, Ozluk OA, Tutuncu A, Yagcioglu P, et al. Evaluation of Tp-Te interval and Tp-Te/QTc ratio in patients with coronary artery ectasia. Int J Clin Exp Med. 2014;7(9):2865-2870.
    pubmed
  31. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41(6):567-574.
    doi pubmed
  32. Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, Mabuchi T, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci (Lond). 2003;105(6):671-676.
    doi pubmed
  33. Tieleman RG, Crijns HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J. 1995;73(1):37-40.
    doi pubmed
  34. Higham PD, Furniss SS, Campbell RW. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J. 1995;73(1):32-36.
    doi pubmed
  35. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63(6):342-344.
    doi pubmed
  36. Mahmoud K. Effect of isolated coronary artery ectasia on dispersion of P-wave and QT interval. The Egyptian Heart Journal. 2012;64:121-125.
    doi
  37. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135(5 Pt 1):733-738.
    doi
  38. Gialafos JE, Dilaveris PE, Gialafos EJ, et al. P dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol. 1999;4:39-45.
    doi


This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Cardiology Research is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Cardiology Research, bimonthly, ISSN 1923-2829 (print), 1923-2837 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.

This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.cardiologyres.org   editorial contact: editor@cardiologyres.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.